Coming Together to Address America’s STD Crisis
We are in a time of crisis when it comes to STDs in the United States and the work of state, local, and territorial STD programs has never been more important.
We are in a time of crisis when it comes to STDs in the United States and the work of state, local, and territorial STD programs has never been more important.
A multi-sector approach to social determinants of health, involving public health and payer entities is vital to improving health outcomes for all populations.
To gain an in-depth perspective on how state public health agencies can promote awareness about the dangers of menthol cigarettes and reduce their consumption, ASTHO spoke with Delmonte Jefferson, and Shyanika Rose, and Jessica Rath.
In this ASTHO Member Spotlight, Esther Muña of the Commonwealth of the Northern Mariana Islands discusses her routine, professional influences, and public health priorities.
Newsroom Newsroom ASTHO news, experts, in the news ASTHO's newsroom houses press releases and statements on recent public health issues. ASTHO can connect the press to state and territorial health officials for stories related to ...
ASTHO Statement on House FY25 Labor-HHS Appropriations Bill appropriations bill, fiscal year, public health programs, substance abuse, mental health, centers for disease control and prevention, territorial health departments, optimal ...
ASTHO Appoints Joseph Kanter, MD, MPH, as New Chief Executive Officer ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) today announced that Joseph Kanter, MD, MPH, has been named as the organization's ...
ASTHO Welcomes New Leadership to Executive Team executive leadership, public relations, director of communications, nebraska department of health and human services, chief of staff, national public health information coalition, data ...
On October 25, 2023 ASTHO announced that Steven Stack, MD, MBA was named ASTHO's 81st president.
On May 2, 2023, ASTHO released a statement of support for the President’s Council of Advisors on Science and Technology’s new report and recommendations for supporting the U.S. public health workforce.
On March 22, 2023, ASTHO released a statement on EPA's newly-proposed drinking water rule for six PFAS substances.
On March 10, 2023, ASTHO announced that several organization experts, including ASTHO staff, leadership, and former state health officials, are featured in the March issue of Health Affairs, which is focused on public health lessons during ...
On Jan. 30, 2023, ASTHO released a statement commending the FDA on a new proposal to conduct individual risk assessments for blood donors, a policy that reflects the best available science while not promoting stigma and discrimination ...
On Sept. 9, 2021, ASTHO CEO Michael Fraser, PhD, issued a statement of support for President Biden's action plan, "Path Out of the Pandemic."
On March 11, 2021, ASTHO CEO Michael Fraser released a statement applauding Congress and the Biden administration on the passage of the American Rescue Plan Act of 2021.
On Feb. 24, 2021, ASTHO member and public health leader Ngozi Ezike, MD, director of the Illinois Department of Public Health, testified before the House Homeland Security Committee. Ezike answered questions in the hearing, ...
On Feb. 2, 2021 ASTHO and the assembly of members pledged to ensure equitable access of the COVID-19 vaccine and to collect accurate demographic data to assure detection and response to any potential disparities in vaccine administration.
On Feb. 2, 2021, ASTHO members and public health leaders Jill Hunsaker Ryan, MPH of Colorado, Ngozi Ezike, MD of Illinois, and Joneigh Khaldun of Michigan testified before a House subcommittee. Each panelist responded to questions from ...
On Oct. 13, 2022, ASTHO CMO Marcus Plescia released a statement supporting ACIP's decision to encourage adding COVID-19 vaccinations to standard immunization schedules.
ASTHO Commends FDA for Strong Action to Remove Juul E-Cigarette Products from the Market ARLINGTON, VA—Yesterday, the U.S. Food and Drug Administration (FDA) issued marketing denial orders to Juul Labs Inc. for their Juul device and their ...